HYACORP FACE®

The administration protocol of HYACORP FACE® ensures maximum effectiveness and patient safety through precise injection methods:

• Injection into medium dermal tissue.
• No overcorrection; only correct to 100% of the desired volumizing effect.
• Recommended pre-treatment marking of injection sites.
• Optional local anesthetic for increased patient comfort.
• Antibiotic prophylaxis may be applied at the practitioner’s discretion.
• Follow-up evaluations advised to monitor results and manage complications if necessary.

HYACORP FACE® is specifically indicated for the aesthetic enhancement and volume correction of facial features:

• Indications:
  • Medium to deep wrinkle filling.
  • Restoration of facial contours and volume.
  • Cheek augmentation, nasolabial folds, glabella folds.
• Contraindications:
  • Hypersensitivity to hyaluronic acid or gram-positive bacteria.
  • Tendency toward hypertrophic or keloid scarring.
  • Active inflammatory or infectious skin conditions.
  • Current anticoagulant therapy.
  • Acute or chronic skin diseases.
  • Autoimmune disorders.
  • Not suitable during pregnancy, breastfeeding, or for individuals under 18.
  • Not intended for breast or genital augmentation.
• Possible Side Effects:
  • Immediate reactions: itching, redness, swelling, tenderness, bruising, or hematoma.
  • Rare delayed reactions: infections, biofilm formation, chronic inflammatory nodules, herpes reactivation, filler migration, skin necrosis, granulomas, foreign body reactions.
  • Injection-related risks include overcorrection or bluish discoloration (Tyndall effect).

HYACORP FACE® contains carefully selected ingredients, ensuring safety and compatibility with human dermal tissues:

• Ingredients:
  • Hyaluronic Acid: 2.0 mg/ml (non-cross-linked)
  • Cross-linked Hyaluronic Acid: 20.0 mg/ml
  • Sodium Chloride: 6.9 mg/ml
  • Water for injection: up to 1 ml
• Packaging:
  • Sterile pre-filled 1 ml syringe with Luer Lock adapter
  • Two sterile needles (EO sterilized)
  • Packaged in single-use, steam-sterilized blister pack
  • Traceability labels included with batch number and expiry date provided to patient

Proper administration of HYACORP FACE® involves careful preparation and precise injection techniques to achieve the intended aesthetic outcome safely.

• Clearly mark the areas to be treated prior to injection.
• Administer local anesthetic if required to minimize discomfort.
• Remove syringe from sterile blister pack, attach suitable sterile needle to the Luer Lock connector.
• Inject the gel slowly and evenly into medium dermal tissue without exceeding the required volumetric correction.
• Avoid massaging or applying excessive pressure to the treated area for several days post-injection.

Post-procedure recommendations:

• Avoid exposure to extreme heat (sun, solarium, laser, IPL) or extreme cold.
• Suspend vigorous physical activity for several days after treatment.
• Practitioners must verify the injected volume visually and through palpation, ensuring even distribution and avoiding overcorrection.